7-bromo-5-fluoro-1,4-dihydroquinazolin-4-one, 98%, 250mg

5-Bromo-2,3-dihydro-1-benzofuran-7-sulfonyl chloride, 97%, 250mg

(S)-2-(4-Bromophenyl)piperidine, 95%, 250mg

5-chloro-1-(4-methoxyphenyl)-3-(propan-2-yl)-1H-pyrazole-4-carbaldehyde, 95.0%, 2g

Benzyl (3-bromo-4-fluorophenyl)carbamate, 95.0%, 250mg

ethyl (benzylamino)(oxo)acetate, 95.0%, 1g

4-Bromo-2-furoic acid, 95.0%, 250mg

Volumetric flasks with glass stopper, class A Trapezoidal shape, 10 ml, 7/16, 2 Piece(s)

4,4'-Bipyridinium, 1,1'-dipropyl-, dibromide, 97%, 250mg

2-(Pyrrolidin-3-yl)ethanol hydrochloride, 95.0%, 5g

4-Bromo-5-chloro-2-fluoroaniline, 95.0%, 25g

4-(Benzyloxy)-2-methoxybenzaldehyde, 97.0%, 1g

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)